PMID: 11922903Mar 30, 2002Paper

Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation

Cardiovascular Research
K KunisadaK Yamauchi-Takihara

Abstract

We recently reported that doxorubicin (Dox), an effective anti-cancer drug, induces apoptosis in cardiac myocytes in association with reduction of Bcl-xl expression. In the present study, we further examined whether overexpression of Bcl-xl ameliorates Dox-induced cardiac myocyte damage. Overexpression of the Bcl-xl gene by adenovirus vector resulted in an 11-fold increase in Bcl-xl protein in neonatal rat cardiac myocytes (BCL) compared to that in cells with beta-galactosidase gene transfection (CTL). Although Dox treatment generated similar amounts of reactive oxygen species (ROS) in BCL and CTL, cell viability was maintained and the number of apoptotic cardiac myocytes was significantly decreased in BCL. Cytochrome c release and enhanced caspase-3 activity after Dox treatment were significantly suppressed and Bax expression level was decreased in BCL. Cardiac-specific gene expression is known to be inhibited by Dox. The expression of cardiac alpha-actin and sarcoplasmic reticulum Ca(2+)-ATPase 2a mRNA was equally inhibited in BCL and CTL after Dox treatment. Overexpression of Bcl-xl in cardiac myocytes failed to regulate Dox-induced ROS generation and cardiac-specific gene downregulation but inhibited apoptosis accompanied b...Continue Reading

Citations

Jan 14, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Junfeng AnStefan Donath
Feb 11, 2014·European Journal of Pharmacology·Eman M MantawyEbtehal El-Demerdash
Jul 18, 2006·Biochemical and Biophysical Research Communications·Simone GretheM Isabella Pörn-Ares
Jul 28, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Silvia Pérez LópezAurora Astudillo González
Aug 24, 2010·Aging Cell·Stephen MorrissyQin M Chen
Nov 26, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Li JingShuangqing Peng
Nov 19, 2015·International Journal of Molecular Sciences·Zodwa DlaminiRodney Hull
Mar 16, 2013·Medicinal Research Reviews·Filipa S CarvalhoPaulo J Oliveira
Apr 3, 2016·Experimental Biology and Medicine·Dina S El-AgamyMohamed A Elkablawy
Aug 4, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Jeevan Kumar JadapalliGanesh V Halade
May 9, 2006·Shock·Diane L M Hickson-BickL Maximilian Buja
Oct 15, 2008·Transplantation·Silvia Pérez LópezJesús Otero Hernández
Apr 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Tomas G NeilanDesmond J Fitzgerald
Apr 1, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stefano FogliMaria Cristina Breschi
Mar 12, 2013·Journal of Cardiovascular Pharmacology·Anne-Katrin PolanskiCarsten Wunderlich
Dec 20, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Kamilia M IbrahimEbtehal El-Demerdash
Aug 7, 2021·Saudi Journal of Biological Sciences·Nemat AliMohammed M Alanazi
Apr 10, 2009·European Journal of Pharmacology·Hong XinYi Zhun Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.